I like:
- Increase of 121% on the March quarter 2019.
- Financial year-end Cash Receipts to June 2019 of $32,221,000 wereup 36% compared to the prior financial year (to June 2018).- This indicates that more EPP patients in Europe arereceiving treatment with SCENESSE® and we look forward to the time the same treatment access can be provided toAmerican EPP patients who have no current alternatives.”
- Net Cash from Operations was positive by $8,618,000 in the June quarter 2019. Net Cash from Operations for thetwelve months to 30 June 2019 was a positive $18,382,000 compared to a positive $11,693,000 in the same twelvemonth period to 30 June 2018.
- Increasing cash balance - Cash Balance as at 30 June2019 increased to $54,269,000, compared to $44,975,000 as at 31 March 2019 and $36,198,000 as at 30 June 2018.
Very positive outlook and building blocks foundation.
Well done!
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$15.25 |
Change
-0.130(0.85%) |
Mkt cap ! $763.0M |
Open | High | Low | Value | Volume |
$15.38 | $15.45 | $15.12 | $1.254M | 82.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 77 | $15.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 63 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 99 | 15.240 |
2 | 11 | 15.230 |
1 | 35 | 15.220 |
5 | 191 | 15.210 |
3 | 131 | 15.200 |
Price($) | Vol. | No. |
---|---|---|
15.260 | 269 | 15 |
15.270 | 333 | 9 |
15.280 | 104 | 2 |
15.290 | 298 | 4 |
15.300 | 624 | 8 |
Last trade - 13.38pm 27/06/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |